W: decision granting a waiver in all age groups for all conditions or indications
Decision date
Decision
P/0126/2018: EMA decision of 11 April 2018 on the granting of a product specific waiver for ezetimibe / rosuvastatin (Zenon, Suvezen), (EMEA-001344-PIP02-17)